114 related articles for article (PubMed ID: 30273070)
1. Dietary Garcinol Arrests Pancreatic Cancer in p53 and K-ras Conditional Mutant Mouse Model.
Saadat N; Akhtar S; Goja A; Razalli NH; Geamanu A; David D; Shen Y; Gupta SV
Nutr Cancer; 2018 Oct; 70(7):1075-1087. PubMed ID: 30273070
[TBL] [Abstract][Full Text] [Related]
2. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures.
Parasramka MA; Ali S; Banerjee S; Deryavoush T; Sarkar FH; Gupta S
Mol Nutr Food Res; 2013 Feb; 57(2):235-48. PubMed ID: 23293055
[TBL] [Abstract][Full Text] [Related]
3. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.
Dosch JS; Ziemke EK; Shettigar A; Rehemtulla A; Sebolt-Leopold JS
Cancer Res; 2015 Nov; 75(21):4582-92. PubMed ID: 26359451
[TBL] [Abstract][Full Text] [Related]
5. The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine.
Chen SM; Chieng WW; Huang SW; Hsu LJ; Jan MS
Sci Rep; 2020 Nov; 10(1):20319. PubMed ID: 33230218
[TBL] [Abstract][Full Text] [Related]
6. K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.
Réjiba S; Wack S; Aprahamian M; Hajri A
Cancer Sci; 2007 Jul; 98(7):1128-36. PubMed ID: 17489984
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment.
Schwarz RE; Donohue CA; Sadava D; Kane SE
Cancer Lett; 2003 Jan; 189(1):59-68. PubMed ID: 12445678
[TBL] [Abstract][Full Text] [Related]
8. Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
Mohammad RM; Li Y; Mohamed AN; Pettit GR; Adsay V; Vaitkevicius VK; Al-Katib AM; Sarkar FH
Pancreas; 1999 Nov; 19(4):353-61. PubMed ID: 10547195
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Factor Erythroid 2-Related Factor 2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression.
Matsumoto R; Hamada S; Tanaka Y; Taguchi K; Yamamoto M; Masamune A
J Pharmacol Exp Ther; 2021 Oct; 379(1):33-40. PubMed ID: 34321315
[TBL] [Abstract][Full Text] [Related]
10. Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways.
Wang J; Wu M; Zheng D; Zhang H; Lv Y; Zhang L; Tan HS; Zhou H; Lao YZ; Xu HX
Acta Pharmacol Sin; 2020 Jan; 41(1):82-92. PubMed ID: 31371781
[TBL] [Abstract][Full Text] [Related]
11. Metformin suppresses tumor angiogenesis and enhances the chemosensitivity of gemcitabine in a genetically engineered mouse model of pancreatic cancer.
Qian W; Li J; Chen K; Jiang Z; Cheng L; Zhou C; Yan B; Cao J; Ma Q; Duan W
Life Sci; 2018 Sep; 208():253-261. PubMed ID: 30053447
[TBL] [Abstract][Full Text] [Related]
12. [Pancreatic cancer].
Schmid RM
Praxis (Bern 1994); 2006 Nov; 95(44):1709-12. PubMed ID: 17111879
[TBL] [Abstract][Full Text] [Related]
13. In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models.
Russell J; Pillarsetty N; Kramer RM; Romesser PB; Desai P; Haimovitz-Friedman A; Lowery MA; Humm JL
Mol Imaging Biol; 2017 Dec; 19(6):885-892. PubMed ID: 28349292
[TBL] [Abstract][Full Text] [Related]
14. Garcinol exerts anti-cancer effect in human cervical cancer cells through upregulation of T-cadherin.
Zhao J; Yang T; Ji J; Li C; Li Z; Li L
Biomed Pharmacother; 2018 Nov; 107():957-966. PubMed ID: 30257408
[TBL] [Abstract][Full Text] [Related]
15. An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.
Edderkaoui M; Chheda C; Soufi B; Zayou F; Hu RW; Ramanujan VK; Pan X; Boros LG; Tajbakhsh J; Madhav A; Bhowmick NA; Wang Q; Lewis M; Tuli R; Habtezion A; Murali R; Pandol SJ
Gastroenterology; 2018 Dec; 155(6):1985-1998.e5. PubMed ID: 30144430
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy.
Camp ER; Wang C; Little EC; Watson PM; Pirollo KF; Rait A; Cole DJ; Chang EH; Watson DK
Cancer Gene Ther; 2013 Apr; 20(4):222-8. PubMed ID: 23470564
[TBL] [Abstract][Full Text] [Related]
17. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of a Gloriosa superba extract improves the in vivo antitumoural activity of gemcitabine in a murine pancreatic tumour model.
Capistrano I R; Vangestel C; Vanpachtenbeke H; Fransen E; Staelens S; Apers S; Pieters L
Phytomedicine; 2016 Nov; 23(12):1434-1440. PubMed ID: 27765363
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
[TBL] [Abstract][Full Text] [Related]
20. Predicting Gemcitabine Delivery by
Russell J; Grkovski M; O'Donoghue IJ; Kalidindi TM; Pillarsetty N; Burnazi EM; Kulick A; Bahr A; Chang Q; LeKaye HC; de Stanchina E; Yu KH; Humm JL
J Nucl Med; 2021 Feb; 62(2):195-200. PubMed ID: 32646874
[No Abstract] [Full Text] [Related]
[Next] [New Search]